Trends in Alzheimer Imaging & Management
In this discussion, Dr Tanenbaum, Ana Franceschi, MD, associate professor of radiology at Lenox Hill Hospital, Hofstra/Northwell in New York City; and Adam Samchuck, senior product manager for PET Solutions at Siemens Healthineers, North America, explore the evolving role of molecular imaging in Alzheimer disease (AD) diagnosis, as well as the impact of emerging AD therapeutics.
5 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der Trends in Alzheimer Imaging & Management-Community!